HB 201  - AS INTRODUCED
 
 
2021 SESSION
21-0385
10/06
 
HOUSE BILL 201
 
 
SPONSORS: Rep. McBeath, Rock. 26
 
COMMITTEE: Commerce and Consumer Affairs
 
-----------------------------------------------------------------
 
ANALYSIS
 
This bill requires the commissioner of insurance to review the implementation of the requirement for coverage of pediatric autoimmune neuropsychiatric disorders as adopted by 2019, 277 (SB 244-FN) and to report to the legislature.
 
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
 
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
21-0385
10/06
 
STATE OF NEW HAMPSHIRE
 
In the Year of Our Lord Two Thousand Twenty One
 
 
Be it Enacted by the Senate and House of Representatives in General Court convened:
 
1  Insurance; Certain Biologically-based Mental Illnesses; Pediatric Autoimmune Neuropsychiatric Disorders; Review and Report.  The commissioner of the insurance department shall review the implementation of the requirement in RSA 417-E:1, II as amended by 2018, 277 to provide insurance coverage for pediatric autoimmune neuropsychiatric disorders, when treatment, including the use of intravenous immunoglobulin therapy, is ordered by a physician.  Following such review, the commissioner shall issue a report, not later than November 1, 2021, to the chairpersons of the house and senate standing committees with jurisdiction over insurance matters.
2  Effective Date.  This act shall take effect upon its passage.